AlzChem Group Financials
| ACT Stock | EUR 57.40 0.20 0.35% |
AlzChem |
Understanding current and past AlzChem Group Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of AlzChem Group's financial statements are interrelated, with each one affecting the others. For example, an increase in AlzChem Group's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in AlzChem Group's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of AlzChem Group AG. Check AlzChem Group's Beneish M Score to see the likelihood of AlzChem Group's management manipulating its earnings.
| Foreign Associate | USA |
| Instrument | Germany Stock View All |
| Exchange | Munich Exchange |
| Benchmark | Dow Jones Industrial |
| Currency | EUR - Euro |
You should never invest in AlzChem Group without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of AlzChem Stock, because this is throwing your money away. Analyzing the key information contained in AlzChem Group's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
AlzChem Group Key Financial Ratios
AlzChem Group's financial ratios allow both analysts and investors to convert raw data from AlzChem Group's financial statements into concise, actionable information that can be used to evaluate the performance of AlzChem Group over time and compare it to other companies across industries.AlzChem Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AlzChem Group's current stock value. Our valuation model uses many indicators to compare AlzChem Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AlzChem Group competition to find correlations between indicators driving AlzChem Group's intrinsic value. More Info.AlzChem Group AG is rated fifth in current valuation category among its peers. It is rated second in price to book category among its peers . The ratio of Current Valuation to Price To Book for AlzChem Group AG is about 193,568,809 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AlzChem Group's earnings, one of the primary drivers of an investment's value.AlzChem Group AG Systematic Risk
AlzChem Group's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. AlzChem Group volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on AlzChem Group AG correlated with the market. If Beta is less than 0 AlzChem Group generally moves in the opposite direction as compared to the market. If AlzChem Group Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one AlzChem Group AG is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of AlzChem Group is generally in the same direction as the market. If Beta > 1 AlzChem Group moves generally in the same direction as, but more than the movement of the benchmark.
AlzChem Group December 16, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of AlzChem Group help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of AlzChem Group AG. We use our internally-developed statistical techniques to arrive at the intrinsic value of AlzChem Group AG based on widely used predictive technical indicators. In general, we focus on analyzing AlzChem Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build AlzChem Group's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.97 | |||
| Information Ratio | 0.1051 | |||
| Maximum Drawdown | 20.6 | |||
| Value At Risk | (4.03) | |||
| Potential Upside | 8.9 |
Additional Tools for AlzChem Stock Analysis
When running AlzChem Group's price analysis, check to measure AlzChem Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AlzChem Group is operating at the current time. Most of AlzChem Group's value examination focuses on studying past and present price action to predict the probability of AlzChem Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AlzChem Group's price. Additionally, you may evaluate how the addition of AlzChem Group to your portfolios can decrease your overall portfolio volatility.